The unwavering quest for effective treatments for Alzheimer's disease has resulted in the identification of numerous therapeutic targets, each with the potential to stop or reverse the neurodegenerative processes linked to this devastating disorder. In the upcoming Alzheimer's 2024 conference, a dedicated scientific session will delve into the latest research on therapeutic targets, presenting promising strategies that challenge conventional approaches and bring renewed hope to individuals affected by Alzheimer's disease.
This session will explore a varied range of therapeutic targets, including proteins, signaling pathways, and cellular processes crucial in Alzheimer's disease pathology. Experts will share their pioneering research on addressing neuroinflammation, synaptic dysfunction, and neuroprotective mechanisms, providing fresh insights into potential treatment approaches.
All accepted abstracts will be published in respective Allied Academies Journals.
Abstracts will be provided with Digital Object Identifier by
